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Abstract-The C4a anaphylatoxin was purified from rat sera activated by heat-aggregated IgG. The 
anaphylatoxin was isolated by a three-step purification procedure and was judged to be homogeneous 
based on visualization of a single stained band after electrophoresis on both cellulose acetate membrane 
strips and on 9% SDS-polyacrylamide gels. Results from Ouchterlonv and radioimmunoassav analvsis 
indicated that neither rat C5A nor C3a contaminated the C4a preparation. Rat C4a is a glycoproiein 
estimated to be 11.00~12.000 mol. wt and contains 76 amino acid residues representing a mol. wt of 8577 
and one oligosaccharide unit of 200&3000 mol. wt. Rat C4a is weakly actice in contracting guinea pig 
ileum at 0.1-I pLM, which is comparable with the activity of human C4a. Both human and bovine C4a 
are polypeptides free of carbohydrate while rat and presumably mouse C4a are glycoproteins. The 
complete primary structure of rat C4a anaphylatoxin has been elucidated as follows: 
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There are three complement derived anaphylatoxins, 
identified as C3a, C4a and C5a, and each display a 
variety of biological activities and have correspond- 
ingly distinct chemical characteristics. It has been 
shown that human C4a possesses weak spasmogenic 
activity both for inducing smooth muscle contraction 
and for enhancing vascular permeability (Gorski et 
al., 1979). We have suggested that C4a functions as 
an anaphylatoxin and is genetically related to C3a 
and CSa (Hugli, 1984). Functional studies of syn- 
thetic peptides based on the COOH-terminal se- 
quence of human and rat C4a provide perhaps the 
most convincing evidence that C4a is biologically 
related to the C3a anaphylatoxin (Hugli et al., 1975). 
Analog synthetic pentapeptides based on the COOH- 
terminal sequence of human (AGLQR) and rat 
Abbreviations: PE-C4a,,,.,, pyridylethylated-C4a,,.,; 
PAS, periodic acid Schiff’s stain; SDS-PAGE, sodium 
dodecyl sulfate-polyacrylamide gel electrophoresis; Slp, 
sex-limited protein is a class II product of the murine 
major histocompatibility complex and is presumed to 
arise from gene duplication of the mouse C4 gene; CpB, 
carboxypeptidase B; CpY, carboxypeptidase Y; PTH- 
AA, phenylthiohydantion derivative of amino acid. 
(AGLAR) C4a were 0.05 and 17-25% as active, 
respectively, as was a pentapeptide LGLAR from 
human C3a in the ileal assay (Hugli et al., 1983). 
Human C4a exhibits spasmogenic activity at levels of 
1&20pg/ml and based on the relative activity of 
synthetic peptide analogs rat C4a should be consid- 
erably more active than human C4a. On a molar 
basis, human C4a is less potent in all assays than are 
either C3a or C5a anaphylatoxins. 
The primary structure of human C4a (Moon et al., 
1981) shows greater homology with C5a than with 
C3a. However, C4a is functionally related to C3a and 
not C5a based on cross-tachyphylaxis of the guinea 
pig ileum by C3a and C4a. Extending the studies of 
C4a to the rat system provides new insight into the 
relationships between structure and function of C4a. 
Furthermore, since C4a is generated specifically from 
activation of the classical complement pathway by 
antigen-antibody complex interaction with Cl, anti- 
rat C4a,,, Arg antibody provides a useful reagent in 
developing immunoassays for detecting C4 con- 
version in this popular animal model. An immuno- 
assay for rat C4a will prove useful in monitoring the 
course of immunologic diseases that involve the 
classical complement cascade in the experimental rat 
model. 
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MATERIALS AND METHODS 
Bio-Gel P-60 and QAE Sephadex were obtained 
from Bio-Rad and Sigma Chemical Company, 
respectively. The Mono S HR S/5 column was 
purchased from Pharmacia. Pooled rat serum was 
collected from two outbred strains (Wistar and 
Sprague-Dawicy) of male and female animals by 
the Biotroi Company. The 2-mercaptomethyl-3- 
guanidino-ethyithiopropanoic acid was obtained 
from Calbiochem. La Jolla. N-Glycanase’“- 
(peptide: N-glycosidase F, peptide-~4-[~-acetyl-bet~- 
glucosaminyl] asparagine amidase) was purchased 
from Gcnzyme Corp., Boston, MA. All other re- 
agents and solvents were of the highest chemical 
purity available. 
Anaphylatoxin activity was assessed by measuring 
the contraction of terminal strips of guinea pig ileum 
(Cochrane and Miller-E~rhard, 1968). 
P~ri~cut~o~ of rat C4a a& C4a,,, Alp 
Two liters of rat serum was activated by adding 1 g 
of heat-aggregated (64 C for 60 min) human IgG in 
the presence of 2mM serum carboxypeptidase N 
inhibitor, 2-mer~~ptonlethyi-3-guanid~no-ethyithio- 
propanoic acid (Hugli et al., 1982). The activated 
serum was acidified by slowly adding concentrated 
HCI to a final concentration of 1 N HCI and the 
precipitate was centrifuged. The supernatant, con- 
taining acid soluble proteins including the anaphyla- 
toxins, was dialyzed against water in a small pore 
tubing then neutralized to pH S-6 and lyophilized. 
Gel filtration of the lyophitized material redis- 
solved in 400 ml of 0.05 A4 ammonium formate was 
performed at 4’C on a Bio Gel P-60 column 
(15 x 60cm). 
Elution from the P-60 column with 0.05 itp ammo- 
nium formate at pH 5.0 was the first step of rat C&a 
purification. Initially the effluent was monitored by 
assaying for activity of the combined anaphyiatoxins 
using the guinea pig iieal bioassay. Later the isolated 
C4a was radioiodinated with “‘1 and elution was 
monitored as radioactivity (see Fig. 1). The fractions 
containing anaphylatoxin activity were pooled and 
fractionated further by applying the material to a 
QAE-Sephadex Q-50 column (1.8 x 20 cm), equih- 
brated with 0.05 M ammonium bicarbonate at pH 8.6 
and developed using isocratic elution. This step re- 
moved a major portion of the contaminating protein 
(Fig. 2). The anaphylatoxin-containing pooi was 
finally subjected to chromatography on a Mono S 
column. The conditions used to develop the Mono S 
column are described in the legend to Fig. 3. 
Preparation of C4ad,,,,,, can be obtained in the 
same manner as C4a except that the serum car- 
boxypeptidase N inhibitor is not added. The 
C4+,, Arg- containing pools obtained from the Bio Gel 
P-60 and then a QAE-Sephadex column was applied 
to the Mono S column and the elution profile is 
shown in Fig. 4. These columns were ail monitored 
by ‘2SI-C4adaArfi radioactivity and 280 nm absorb- 
ance. The material in the pool identified as peak I was 
C4a,,, i\ip. 
Disc polyacryiamide gel eiectrophoresjs was car- 
ried out on 0. I% SDS-9% polyacrylamide gels at 
pH 7.2 (Weber and Qsborn, 1969) and protein bands 
were visualized by staining with Coomassic blue. 
Electrophoresis on cellulose acetate strips was pcr- 
formed in 0.075 M barbital buffer at pH 8.6 using a 
Beckman Model RI01 apparatus at room temp for 
30 min at 200 V, and protein was stained using 
Amido Black. 
C4k, Arg was reduced and alklyatcd with 4-vinyl 
pyridine according to Friedman et al. (1970) prior 
to CNBr digestion. Pyridylethyi-C4ad,,Arg (PE- 
C4a,,, i\rl, ) was dissolved in I ml of 70% formic acid 
containing a 300-fold molar excess of CNBr. After 
incubation for 24 hr at room temp, the reaction 
mixture was diluted to IO ml with cold water and 
lyophiiized. The material was redissolved in 5 ml 01 
water and again iyop~ilized. The dried material was 
dissolved in 0.2 ml of water and the CNBr-peptidcs 
were separated by reverse phase HPLC on a C4 
column (Vydac 5). The elution conditions used are 
described in the legend to Fig. 6. 
Amino acid and seyuence anal_wis 
Automated Edman degradation was performed on 
an Applied Biosystems Model 470A. The PTH amino 
acid derivatives were analyzed by HPLC using an 
automatic Waters HPLC system. 
Amino acid analysis were performed on a Beckman 
i21M analyzer. Cysteine residues in C4a were re- 
duced and alkylated by reaction with 4-vinyl pyridine 
before amino acid analysis was performed. The PE- 
C4a dcaArg or CNBr-digested fragments of PE-C4a,,, nrp 
were placed in ignition tubes, vacuum sealed and 
hydrolyzed at 110°C for 24 hr in constant-boiling 
HCI containing 1% (v/v) phenol. 
Determination of the C-terminal amino acid rcsi- 
dues of C4a was accomplished by carboxypeptidase 
digestion. Rat C4a (2 nM) was dissolved in 1% 
sodium bicarbonate at pH 8.0-X.5 and incubated 
with 2% carboxypeptidase B (w/w) at 37 C. After 
5 mm, 0. I i2/f citric acid-0.2 M HCl buffer was added 
to stop the reaction. Amino acid analysis were 
performed to determine the residues released. 
Carboxy~ptidase Y digestion was performed in 
0.05 M sodium acetate buffer at pH 5.5 and 37°C for 
O-2hr with 4% (w/w) enzyme. The reaction was 
stopped by adding 0.2 M citric acid buffer and amino 
acid analyses were performed. 
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Carbohydrate anal_vsis 
Aliquots containing 1.5 nmol of C4acladesArg were 
loaded on 0.1% SDS-9% polyacrylamide gels and 
disc eiectrophoresis was carried out at pH 7.2 (Weber 
and Osborn, 1969). One gel was stained with Coo- 
massie blue for protein and another was fixed in 
methanol-water-acetic acid (60: 35 : 5) and stained 
for carbohydrate by PAS reagents as described by 
Kapitany and Zebrowsky (1973). 
Deglycosylation of native rat C4a was accom- 
plished by digestion of 20 fig of rat C4a in 0.2 M 
sodium phosphate at pH 8.6 using 7.0~1 of N- 
glycanase (260 units/ml) and incubating for 12 hr at 
37°C (Chu, 1986). The deglycosylated preparation of 
rat C4a was analyzed by SDS-PAGE as described 
above. 
~~F~u~oussa.v analysis 
Monospecific anti-rat C4a was raised in rabbits by 
injecting 50 pg of rat C4adesArg in complete Freund’s 
adjuvant into the popliteal lymph nodes. Two and 
four weeks later the rabbits received intramuscular 
and subcutaneous injections of 50 pg of the antigen 
with incomplete Freund’s adjuvant. One week later 
the rabbits were bled and antiserum was recovered. 
Immunodiffusion analyses (Ouchterlony and Nilsson, 
1978) of isolated rat C4a, rat C3a (Jacobs et al., 1978) 
and rat C5a (Cui et al., 1985) were performed using 
the monospecific anti-rat C4a. Radioimmunoassays 
according to the procedures described by Hugh and 
Chenoweth (1981) were developed for rat C3a and rat 
C5a. Levels of both rat C3a and C5a were determined 
in rat C4a preparations using the radioimmunoassay 
technique at a sensitivity of 20-50 ng/ml. 
RESULTS 
Pur~$ication of rat C4a and C4ad,,,8 
Both intact and des Arg forms of C4a were recov- 
ered from rat sera containing carboxypeptidase N 
inhibitor and activated by heat-aggregated human 
IgG. The results of a three-step procedure for 
purification of C4a are outlined in Figs 1-3. Gel 
filtration and QAE-Sephadex chromatography (Figs 
t and 2) result in a separation of rat C4a from rat C3a 
and most other impurities, but it fails to separate the 
C4a from C5a since both are cationic glycoproteins. 
Resolution of rat C4a and C5a was achieved by 
employing a Mono S column (Fig. 3). Results of 
amino acid analysis suggested that material in pools 
II and IV from the Mono S column was rat C4a and 
pools I and II1 presumably contain rat C4a,,,., (see 
Fig. 3). Although serum carboxypeptidase N in- 
hibitor was present during complement activation 
with aggregated IgG, significant activation appar- 
ently occurred prior to the addition of IgG based on 
the level of C4a,,, Arg obtained. Presumably activation 
is caused both from mixing of serum obtained from 
several strains of animals and as a result of coagu- 
lation enzymes. 
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Fig. 1. Gel filtration of soluble material recovered from 2 1 
of complement-activated rat serum after acid precipitation. 
Separation was performed on a Bio-Gel P60 column 
(15 x 6Ocm) equilibrated with 0.1 M ammonium formate 
buffer at pH 5.0. The column was eluted with 0.1 M ammo- 
nium formate, pH 5.5, at a flow rate of I35 ml/hr and 
fractions of 40ml were collected. Biological activity was 
determined by the guinea pig ileal assay. Active fractions 
(3.5-80) coincided with radioactivity from [‘ZSI]C4aderAre that 
was introduced in the original serum sample. Material in 
pool II was recovered for chromatography on the OAE- 
Sephadex column. 
Rat plasma drawn into EDTA contains 1.08 pg/ml 
of C4a and plasma drawn into heparin has 
0.99 pg/ml of C4a which is 5-lo-fold higher than 
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Fig. 2. Chromatography of material in pool II from the Bio 
Gel P-60 column was performed on a 1.8 x 20cm QAE- 
Sephadex (Q-50) column equilibrated with 0.05 M ammo- 
nium bicarbonate at pH 8.6. Material in pool II collected 
from Bio Gel P-60 filtration was aoalied to the OAE- 
Sephadex column after dialysis, lyo~~ii~ati~~ and being 
redissolved in 1-2 ml of the pH 8.6 buffer. Isocratic elution 
was performed with 0.05M ammonium bicarbonate at 
pH 8.6 at a flow rate of IO-12 ml/hr. Fractions of 2.5 ml 
were collected and biological activity was determined using 
the guinea pig ileal assay. Note that C4a and C5a activity 
was indistinguishable and overlapping at this step. The rat 
C3a elutes in pool I as the most cationic of the three 
anaphylatoxins (Jacobs et al., t978). 
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Fig. 3. Chromatography of C4a on a Mono S column. The 
anaphylatoxin-containing pools II and III from QAE- 
Sephadex were applied to a Mono S (HR 5/5) column. 
Solvent A: 0.1 M ammonium formate at pH 7.0. Solvent B: 
0.8 M ammonium formate at pH 7.0. A linear gradient was 
developed over 10 min from 100% solvent A to 90% solvent 
A containing 10% solvent B. A 90% A/IO% B solvent was 
maintained for 7 min and then another linear gradient from 
10% solvent B to 100% solvent B was developed over 5 min. 
Elution with 100% solvent B was maintained for 8 addi- 
tional min and returned to 100% solvent A. The absorbance 
setting was 0.02 O.D. units full scale. Both pools II and IV 
were concluded to contain C4a material based on amino 
acid analysis. We speculate that variations in sialic acid 
content may account for the multiple peaks of C4a. 
heparin plasma. The C4a in rat serum was 
7.63 + 4.78 pgg/ml (n = 48) or nearly half of the C4a 
expected from total conversion of C4. As in the 
plasma, we observed nearly IO-fold higher levels of 
C4a in fresh rat serum than in human serum. These 
results indicate that the predominant mechanism of 
C4 conversion during plasma or serum collection is 
initiated by enzymes of the coagulation cascade. 
The major peak from a Mono S (Fig. 4) separation 
of material obtained by activating serum in the 
absence of carboxypeptidase N inhibitor contains the 
des Arg derivative of rat C4a. The materials in pool 
IV from Fig. 3 and in pool I from Fig. 4 are nearly 
identical based on compositional analysis except for 
the arginine content (see Table 1). When the material 
recovered from the Mono S column was applied to 
cellulose acetate strip electrophoresis (Fig. 5A), a 
single stained protein band was revealed indicating 
that intact C4a (lane 3) and C4adeiArg (lane 2) were 
homogeneous. Electrophoretic behavior of C4a on 
SDS-polyacrylamide gels (Fig. 5B) also shows a 
single band (gel 3) when stained with Coomassie blue. 
Positive staining of C4a in the SDS gels with PAS- 
reagent (gel 4) proved that rat C4a, like human CSa 
(gels 5 and 6) is a glycoprotein. Preparations of rat 
C4a and C4a,,, Arg obtained by the three-step isolation 
procedure were used in all the structural analysis and 
functional tests described below. Yields of approxi- 
Fig. 4. Chromatography of rat C4a,,,,,, on a Mono S 
column. Serum was activated by aggregated IgG without 
serum carboxypeptidase N inhibitor present and the 
anaphylatoxin-containing pool from Bio Gel P60 and QAE- 
Sephadex was applied to a Mono S (HR 5,i5) column. 
Solvent A: 0.1 M ammonium formate at pH 7.0. Solvent B: 
0.8 M ammonium formate at pH 7.0. A linear gradient was 
developed at 1 ml/min from 100% solvent A to 27% solvent 
B in 5.4 min and isocratic elution with 27% solvent B was 
maintained for 35 additional min. Pool I was determined to 
be rat C4a,,, Aig. 
mately l-2 mg each of C4a and C4adrrArg are re- 
covered from 2 I of rat serum. 
Anaphylatoxin activity of rat C4a 
Both C4a and C4adcsArg were tested for anaphyl- 
atoxin activity. The results of the guinea pig ileal 
assay are given in Table 2 and only the intact C4a 
molecule is spasmogenic. Rat C4adelArg is inactive at 
a concentration of up to IO I’M. Rat C4a elicits 
contraction of smooth muscle at a concentration of 
0.1-I pM, or approximately 3-fold greater activity 
than that of human C4a. Human C4a is active at a 
Table I. Amino acid compositmn of rat C4a and C4a,,,,,, 
C4a,,, AT% C4a” 
Amino acid (residues/mole) (residues;mole) 
Lysine 4.90 (5) 4 x9 (5) 
Arginine 8.14 (8) 9.01 (9) 
Aspartlc acid 5.99 (6) 6.3X (6) 
Threonine 3.75 (4) 3.68 (4) 
Serine 4.26 (5) 4.51 (5) 
Glu&mic acid 11.23(11) I I .O5 (I I ) 
Proline 5.57 (5) 5.54 (5) 
Glycine 3.20 (3) 3.02 (3) 
Alanine X.15(X) 7.X6 (8) 
Half-cystine 6.27 (6)” 6.0 (6)’ 
Valine 2.00 (2) 2 03 (2) 
Methionine 2.05 (2) I .40 (2) 
Is&wine 1.18(l) I 09 (I ) 
Leucine 5.26 (5) 5 12(S) 
Tyrosine 1.23(l) 109(l) 
Phenylalanine 2.95 (3) 3 lO(3) 
Total residues: (75)” (76)” 
“Rat C4a was from pool IV of the Mono S column elutmn show” 
m Fig. 3 and rat C4a,,,.,, was from pool I of the Mono S 
column elution shown in Fig. 4. 
“Half-cystine was detected as a pyridylethyl-cysteine denvatwe. 
‘Six half-cystines were assumed from C4a,,,.,, results. 
“Residues in parentheses were taken from the primary struclure 
analysis 
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Fig. S.(A). Microzone electrophoresis of rat C4a (lane 3) 
and rat C4ad,,.,, (lane 2) compared with human C3a (lane 
1) and human CSa (lane 4). Electrophoresis was performed 
for 20 min on cellulose acetate membrane strips at pH 8.6. 
The dashed line indicates the origin for sample application. 
Fig. S.(B). SDS-polyacrylamide gel electrophoresis of human 
C3a (gels I and 2), rat C4a (gels 3 and 4), human C5a (gels 
5 and 6) in 9% acrylamide gels using 0.1% SDS. Protein was 
stained by Coomassie blue (left gel of pair) and carbo- 
hydrate (right gel of pair) was stained by PAS-reagent. 
Table 2. Relative activity of rat C4a, human C4a and human C3a 
in the guinea pig assay 
Factors Effective doses” Relative actwty 
Human C3a &9x 10 VIW 100 
Human C4a I-2 x 10-6 M” 0.5 
Rat C4a 0.1-I x 10 *M 1.5 
Degiycosylated rat C4a 0.5-2 x lo-~/VI 1.0 
“Minimum concentration of factor required to elicit a full con- 
tractmn of guinea pig ileal strip in a 2.0 ml bath. 
‘Cited from Gorski ~1 (I/. (1979). 
concentration of about l&20 pg/ml (1-2 piM) while 
human C3a is active at a level of 0.05 pgg/mI (5 nM). 
Native C4a was readily deglycosylated by digestion 
with N-glycanase and without a requirement for 
detergent. When the deglycosylated rat C4a was 
electrophoresed either SDS-polyacrylamide geis or 
on cellulose acetate strips it migrated faster than 
intact rat C4a moving with rat C3a, which is a 
non-glycosylated anaphylatoxin. Deglycosylated rat 
C4a no longer stained positive with PAS staining and 
all of the glycosylated material was converted based 
on visual inspection of the protein staining pattern 
after eleetrophoresis. Functional analysis indicated 
that removal of the oligosaccharide unit from rat C4a 
had little influence on the spasmogenic activity of the 
molecule (see Table 2). 
It is important to note that prior addition of 
human C3a to the muscle strips blocks rat C4a 
contraction, confining that C3a and C4a are cross- 
ta~hyphylactic factors and are presumed to interact 
with the same cellular receptors. The fact that C3a 
blocks contraction of the muscle by C4a proves that 
the C4a preparation is devoid of rat C5a, since 
CSa-induced contractions are not affected by prior 
exposure to C3a. It is known that CSa is more than 
1000 times as active as C4a on the guinea pig ileum, 
consequently trace quantities of C5a in the C4a 
preparation would be readily detected in the bio- 
assay. 
Amino acid sequence of rut C4a 
Most of the structural analyses were performed 
using the des Arg form of rat C4a. The partial 
NH,-terminal sequence of PE-C4a,,,.,, was estab- 
lished by automated sequence analysis and these 
results are presented in Table 3. This analysis of 
intact C4adesArg p rovided assignments for 33 of the 
NH~-te~inal residues and identified two methionyl 
residues in C4a,,, Arg that are located at positions 28 
and 33. From these results it was concluded that 
CNBr cleavage would produce a large peptide frag- 
ment containing residues 3475, as well as the two 
sequenced fragments 1-28 and 29-33. The HPLC 
separation of a CNBr digest of PE-C4adcsArg was 
performed on a C4 reverse phase column (Vydac 5) 
which resolved the mixture into two major peaks (I 
and II) as shown in Fig. 6. 
Amino acid analyses of the material recovered 
from pools CNBr I and CNBr II are shown in Table 
4. The compositions of the two peptides are dis- 
668 LIANXIAN Cm et ul. 
Table 3. The NH,-terminal primary structure 
of rat PE-C4a,,,,,, determined by automated 
sequence analysis 
Residue Recovery 






































































“Recovery was calculated from I .32 nmole of rat 
PE-C4a,,,,,,. 
*PE-cysteine was positively identified but not 
quantitated. 
tinctive and the composition of peptide from peak I 
clearly indicates that it represents residues 34-75 
(peptide CNBr-II), a fragment from the COOH- 
terminal portion of C4adesArg. A sample of CNBr II 
was subjected to 42 cycles of automated Edman 
degradation and assignment of the sequence of the 
CN II peptide is given in Table 5. 
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Fig. 6. Chromatography of the CNBr peptides derived from 
rat PE-C4a,,, Arg on a Vydac 5 C4 column. Solvent A: 0.1% 
TFA in water. Solvent B: 0.03% TFA in acetonitrile. A 
linear gradient was programmed from 10% solvent B to 
100% solvent B over 45 min at a flow rate of I ml/min. Peak 
I (contained fragments 3475 of rat C4ad,,.,, (peptide CNBr 
II) and Peak II contained fragments 1-28 and 1-33 based 
on amino acid analysis. 
Table 4. Ammo acid analysis of peptides isolated from CNBr 
cleavage of rat PE-C4a,,,,, 
CNBr-I CNBr-II 
Amino acid (residues/mole) (residues!mole) 
Lyune 3.27 (34)” 1.13(l) 
Arginine 1.32 (I) 6.35 (7) 
Aspartic acid 3.40 (4) 2.07 (2) 
Threonine 1.46(1&2) I .X6 (2) 
Serine 2.20 (3) 1.72 (2) 
Glutamic acid 4.62 (4) 7.13(7) 
Proline 2.04 (2) 2.93 (3) 
Glycine 2.03 (2) 1.37(l) 
Alanine 1.69(l) 6 74 (7) 
Half-cystine ND (2)h ND (4)h 
Valine 1.07(l) 0.99 (I) 
Methionine 0.14(1&2) 0.05 (0) 
lsoleucine 0.88 (I) 0.08 (0) 
LeUCl”e 2.04 (l-2) 3.14(3) 
Tyrosine 0.86 (I) 0.1) (0) 
Phenylalanme 1.14(l) I .93 (2) 
Total residues: 2X- 33’ 42 
Yhe number in parentheses were based on expected values from the 
primary structure analysis of rat C4a. 
hIdentitied as PE-cysteine but not quantitated. 
‘Composition suggests mixture of fragments IL28 and I 33. 
Short-term digestion of 2 nmol of C4a with 
carboxypeptidase-B (CpB) indicated that I .07 mol of 
arginine was released per mole of C4a. Carboxy- 
peptidase Y (CpY) digestion of 2 nmol of C4a,,, 4ry 
released the following residues expressed as moles per 
mole of C4adcsArg: Ala I .65, Leu I .Ol, Gly 0.99 and 
Gln 0.47. These results gave further evidence that 
the COOH-terminal sequence of rat C4a is 
Gin-Ala-Gly~LeuAlaaArg. 
Results from the partial NHz-terminal sequence 
analysis of PE-C4a,,, Arg and the CNBr fragment C4a 
34-75, combined with the amino acid analyses of 
residues released from C4a by CpB and by CpY, 
provides a complete primary structure for rat C4a 
(Fig. 7). 
Immunoassay.5 for rut C4a 
The rabbit anti-rat C4a detected only C4a by 
Ouchterlony immunodiffusion analyses and no cross- 
reactivity with purified rat C3a or C5a was observed. 
These results not only indicate that rat C4a is free of 
C3a and C5a, but suggest that these molecules share 
no common epitopes. Radioimmunoassay analysis is 
a more sensitive procedure than immunodiffusion 
and provides a quantitative indication of the levels of 
contamination in rat C4a by C3a or C5a. Radio- 
immunoassay for rat C3a and C5a were each negative 
when the pool of rat C4a form the Mono S column 
containing I mg/ml of rat C4a was tested. Since the 
levels of sensitivity detecting C3a and for C5a using 
this assay procedure is in the range of 20-50 ng/ml. 
we conclude that contamination of rat C4a by C3a or 
C5a is less than 0.002Xi.O05%. 
DISCUSSION 
Rat C4a can be purified from rat serum activated 
by heat-aggregated IgG in the presence of a serum 
carboxypeptidase N inhibitor. However, a significant 
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Table 5. Automated sequence analysis of peptide CNBr-II from rat 
PE-C4a,,,,,, 









































































































































































“Recovery was calculated based on 4.3 “mole of peptide CNBr-II. 
“PE-cysteine was positively identified but recovery was not quan- 
titated. 
‘(X) indicates that residue was not identified. 
quantity of rat C4adesArg is also obtained from serum 
activated in the presence of the potent carboxy- 
peptidase inhibitor. We presume that this C4 con- 
version occurs because serum collected from different 
strains of rats is mixed and heterologous blood group 
antigen-antibody complexes can activate Cl. In addi- 
tion, coagulation enzymes in rat blood contribute 
more to C4 conversion than in human blood based 
on relative C4a levels in plasma and serum. Yields of 
intact C4a, when carboxypeptidase inhibitor was 
added to rat serum (see Fig. 3) prior to activation by 
aggregated IgG, suggests that approximately half of 
the C4 escapes conversion by coagulation enzymes or 
from Cl activated by endogenous immune complex 
formation during blood processing. 
Purity of rat C4a and the C4ad,,,,, derivative 
obtained by a three-step isolation procedure was 
examined by high resolution electrophoresis tech- 
niques. Electrophoretic separations of C4a 
(C4a,,, Arg ) by size or charge each indicated a single 
component. Sensitive radioimmunoassays that were 
specific for rat C3a or rat C5a detected neither factor 
in the C4a preparation. Based on the combined 
characterization results, the C4a fraction from the 
Mono S column was judged homogeneous. Func- 
tional and immunologic characterizations confirmed 
that rat C4a was free of C5a (< 0.1 %), a glycoprotein 
of similar size and charge. 
Rat C4a is a glycoprotein with 76 amino acid 
residues and a molecular weight estimated from 
SDS-gels at 11,200, based on human C5a (Fernandez 
and Hugli, 1978). Determination of the complete 
amino acid sequence of rat C4a permits a comparison 
of this molecule with that of human C4a (Moon et 
al., 1981), bovine C4a (Smith et al., 1982) and mouse 
C4a (Nonaka et al., 1984). As shown in Fig. 8, the 









Fig. 7. The complete amino acid sequence for rat C4a. The N-terminal 33 residues were identified by 
automated sequence analysis of PE-C4a,,, *rg. Residues 34-75 were identified by automated sequence 
analysis of CNBr II (---), Residues released by carboxypeptidase B (---) and Y (---) were designated 
by the arrows. Asn at position 66 was not identified but was assigned based on the amino acid composition 
of CNBr II and the assumption that this was the oligosaccharide attachment site in C4a. 
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Fig. 8. Comparison of the rat Ckd amino acid sequence with that of human C4a, bovine C4a, mouse C4a 
and mouse Sip. Dashes indicate homology with the rat C4a sequence. One deletion is positioned between 
residues 66 and 67 in both rat and mouse sequences compared with human and bovine C4a molecules 
based on maximal homology for neighboring residues. Note that rat C4a. mouse C4a and mouse Slp 
contain 76 residues while human and bovine C4a each contain 77 residues. The CSa and Sip sequences 
were deduced from cDNA clones of C4 obtained from BlO.WR mice. Residues in parentheses identify 
differences in mouse C4a sequences deduced from a C4 cDNA clone obtained from another inbred strain 
of mice (FM). 
between rat C4a and mouse C4a as deduced from the 
cDNA sequence of a clone from the BlO.WR strain 
of mice (Sepich et al., 1985). Only five amino acid 
replacements occur between isolated rat C4a and the 
deduced sequence of mouse C4a from BlO.WR 
(C4w7) mice. Another deduced mouse C4 sequence 
was obtained from a Japanese inbred mouse strain 
FN (Nonaka et al., 1984) and the C4a region in C4M 
contains eight amino acid replacements (identified in 
parentheses in Fig. 8) compared with the rat C4a 
sequence. These results would indicate that the C4w7 
is more like wild-type than is C4FM based on the 
comparison with rat C4a. 
A 75% homology exists between the rat and 
human C4a molecules, including six cysteinyl resi- 
dues and a functionally essential COOH-terminal 
arginyl residue. A deletion of one residue exists in rat 
and mouse C4a when compared with the human C4a 
molecule. We have placed the deletion between posi- 
tions 66 and 67 in the rat C4a based on maximal 
homology between flanking sequences. Comparison 
of the rat C4a sequence with human C5a indicates 
that an unassigned residue located at position 66 in 
rat C4a corresponds with the oligosaccharide binding 
site at position 63 in human C5a. It was therefore 
concluded that the glycosylation site near the C- 
terminus of rat C4a is analogous to that in human 
C5a. Furthermore, the deduced Asn-X-Thr sequence 
of residues 66-68 in rat C4a represents the only 
conventional oligosaccharide attachment site in the 
molecule. A similar glycosylation site exists in mouse 
C4a and mouse Slp; however it is unknown whether 
the mouse proteins are glycosylated. 
Inactivity of rat C4adnArg indicates that rat C4a, 
like all other C3a and C4a anaphylatoxins character- 
ized to date, maintains a strict requirement of a 
C-terminal arginyl residue for biological activity. The 
biologic activity of rat C4a is somewhat greater than 
human C4a in the guinea pig ileal assay. Although 
activity of a synthetic C-terminal analog peptide of 
rat C4a (e.g. AGLAR) is more similar to the human 
C3a pentapeptide LGLAR (Hugli et al., 1983) than 
it is to human C4a analog pentapeptide AGLQR. the 
spasmogenic properties of rat C4a compare more 
closely with human C4a than with C3a. The rat C4a 
C-terminal pentapeptide AGLAR is between 10 and 
25% as active as human C3a LGLAR. Based on the 
fact that the rat C4a pentapeptide AGLAR is more 
than lOO-fold more active as the human C4a peptide 
AGLQR, it remains inexplicable why rat C4a is so 
poorly active compared with human C3a. Obviously. 
the conformation of the C-terminal portion of C4a is 
as important for function as has been demonstrated 
for C3a (Lu et al., 1984). The fact that numerous 
residue substitutions occur near the functionally im- 
portant C-terminus in rat, bovine and human C4a as 
compared to C3a may explain the unexpectedly low 
spasmogenic activity of C4a molecules. 
We examined whether the carbohydrate moiety of 
rat C4a is somehow influencing expression of its 
biological activity. The composition of the carbo- 
hydrate moiety in rat C4a has yet to be determined; 
however the functional role appears not to be a major 
influence since enzymatic removal of the oli- 
gosaccharide unit resulted in no significant enhance- 
ment or reduction of C4a activity. 
Since the rat is a popular experimental model for 
immune disease, the ability to monitor classical path- 
way activation in these animals may prove to be a 
valuable assay system. We and others have dcmon- 
strated that monitoring anaphylatoxin levels in hu- 
man body fluids has been useful in correlating com- 
plement involvement with numerous disease 
processes (Chenoweth et al., 1981; Chenoweth. 1984: 
Hugh and Chenoweth, 1981). The rat antigen C4a 
should prove equally useful as an indicator of classi- 
cal pathway activation in this animal model. Pre- 
liminary evidence suggests that the radioimmunoassay 
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methods of Gorski (1981) for quantitating human 
C4a in physiologic fluids may be adaptable for 
measuring C4 conversion in bodily fluids from the 
rat. Such measurements are valuable in assessing the 
role of complement in experimental models of im- 
mune disease. 
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